Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009–2010: Cohort and case-control study
Authors:
- Jesús CastillaJCJesús Castilla
- Julio MoránJMJulio Morán
- Víctor Martínez-ArtolaVMVíctor Martínez-Artola
- Mirian Fernández-AlonsoMFMirian Fernández-Alonso
- Marcela GuevaraMGMarcela Guevara
- Manuel García CenozMCManuel García Cenoz
- Gabriel ReinaGabriel Reina
- Nerea AlvarezNANerea Alvarez
- Maite ArriazuMAMaite Arriazu
- Fernando ElíaFEFernando Elía
- Esther SalcedoESEsther Salcedo
- Aurelio BarricarteABAurelio Barricarte
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control StudyPLOS Medicine, 2011
- Safety and Effectiveness of a 2009 H1N1 Vaccine in BeijingNew England Journal of Medicine, 2010
- Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networksVaccine, 2010
- Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trialThe Lancet, 2010
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted VaccineNew England Journal of Medicine, 2009
- Response to a Monovalent 2009 Influenza A (H1N1) VaccineNew England Journal of Medicine, 2009
- Critical Care Services and 2009 H1N1 Influenza in Australia and New ZealandNew England Journal of Medicine, 2009
- MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety databaseVaccine, 2009
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in HumansNew England Journal of Medicine, 2009
- Evidence of bias in estimates of influenza vaccine effectiveness in seniorsInternational Journal of Epidemiology, 2005